Position in NVS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$29,507,786
-$1,686,128 QoQ
Shares Held
193,177
-14.6% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
9 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Tidal Investments LLC holds $1,050,650,050 across 16 Drug Manufacturers - General names. NVS ranks #10 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
250,310 | $230,227,627 | |
| 2 | JNJ |
Johnson & Johnson
|
685,005 | $167,442,621 | |
| 3 | AMGN |
Amgen Inc
|
441,940 | $155,496,587 | |
| 4 | ABBV |
AbbVie Inc.
|
497,947 | $108,298,491 | |
| 5 | MRK |
Merck & Co., Inc.
|
895,792 | $107,754,818 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
501,840 | $69,941,439 | |
| 7 | PFE |
Pfizer Inc
|
1,925,435 | $54,066,214 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
708,717 | $42,983,685 |
All Filings in NVS
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $29,507,786 | 193,177 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $31,193,914 | 226,256 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $38,656,152 | 301,436 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,069,849 | 8,841 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $907,112 | 8,137 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $600,597 | 6,172 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $653,313 | 5,680 | Shares | Sole | 2024-11-25 | |
| 2024-06-30 | $486,096 | 4,566 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $279,066 | 2,885 | Shares | Sole | 2024-05-16 | |
| No filing history on record for this holder in this stock. | ||||||